Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 1.3. It has been cited 47 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
Base Score Contribution
0.581
From this paper's citation signal
Citation Network Contribution
0.722
From 25 citing papers with measurable signal
Ranked by each citer's contribution to N(p) â log1p(Cq) divided by its reference count â out of 35 citers.
NIAID NIH HHS
Grant: R01 AI088364
NCATS NIH HHS
Grant: UL1 TR001866
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 5R01AI163029-04
Inborn errors of immunity in patients with life-threatening COVID-19
European Commission
Grant: 824110
European Advanced infraStructure for Innovative Genomics
European Commission
Grant: 101057100
The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine
National Institutes of Health
Grant: 5R01AI088364-15
Inborn errors of immunity in children with herpes simplex encephalitis
French National Research Agency (ANR)
Grant: ANR-21-RHUS-0008
European Commission
Grant: 653316
European Virus Archive goes global
Howard Hughes Medical Institute
Howard Hughes Medical Institute
FWCI
3.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals